Jenny Craig CEO: 'Wellness' Is a Buzzword; Weight Loss Is for Real
*By Carlo Versano*
The buzzword "wellness" has crept into marketing-speak at [practically every turn](https://www.nytimes.com/2019/01/08/style/millennial-marketing-wellness-recess.html) these days. But one company with 35 years of experience in the original wellness trend ー weight loss ー doesn't buy the hype.
We stay away from that word," said Jenny Craig CEO Monty Sharma in an interview on Cheddar Tuesday.
Instead, the weight-loss pioneer is experimenting with new technologies to help its clients lose weight ー and keep it off. This quarter, Jenny Craig will roll out a DNA test that will help dieters customize their own weight loss plans, Sharma said.
"We know more about our bodies today than we ever have," he said, and that includes the different ways people metabolize food based on their genetic makeups. Jenny Craig is following [WW](https://www.cheddar.com/videos/ww-says-celebrity-brand-partnerships-are-key-to-member-growth-chief-brand-officer), formerly Weight Watchers, and [NutriSystem](https://cheddar.com/videos/newly-acquired-nutrisystem-brings-dieting-to-the-masses), which both offer DNA "blueprints" as part of their diet products.
Sharma said the company's year-old "Rapid Results" program has also been successful in helping people tie their eating schedules to their circadian rhythms. Jenny Craig [claims](https://www.jennycraig.com/rapid-results) the science also has ancillary benefits like improving sleep and blood pressure ー real-world wellness indicators.
But at a time of commodified wellness and apps that help you do pretty much everything ー from meditation to improving sleep ー Sharma said the age-old technique of human support remains critical in weight loss. Jenny Craig's strength has always been in its consultations, which make up the backbone of the diet plans, though he added that technology can play a supporting role for self-monitoring purposes.
App retention is low and has not been [shown](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295827/) to be particularly effective on its own for health, Sharma noted.
"It's critical that you have this one-to-one relationship," he said.
For full interview [click here](https://cheddar.com/videos/how-to-navigate-wellness-options-in-crowded-health-field).
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
A look into how disruption, AI, and global economic trends are transforming the modern supply chain with Jeremy Jansen, Head of Supply Chain at Wells Fargo.